ClinicalTrials.gg
Drug

Esketamine clinical trials

Also written S-ketamine, JNJ-54135419 and Spravato.

studies test it
243
open now
83
in phase 3
32
first study started
2005

How each study uses Esketamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Esketamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 Mar 2019 · SPRAVATO · NDA 211243 (FDA, Drugs@FDA)
European Union
18 Dec 2019 · Spravato · EMEA/H/C/004535 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Esketamine
122
Esketamine hydrochloride
14
Esketamine 84 mg
8
Esketamine 56 mg
7
Esketamine Hydrochloride Injection
7

Brand

Spravato
3
Ketanest S
1

Development codes

JNJ-54135419
14

Other names

S-ketamine
23
S-Ketamine 0.25
1
S-Ketamine 0.5
1
S-Ketamine 0.75
1

In one entry with another drug

Given together, or one or the other

Dexmedetomidine-esketamine combination
7
AM-101
5
Esketamine combined with dexmedetomidine
4
S-ketamine and pregabalin
3
Conventional therapy + S (+)-Ketamine
2
Conventional therapy + S-ketamine
2
Conventional therapy + Esketamine
2
Esketamine and remimazolam
2

Studies by the year they started

241 studies that test it; most in 2024 (34); 2 more planned to start later

Studies that test Esketamine, by start year
YearStudies
20051
20061
20071
20093
20114
20123
20132
201412
20158
20169
20177
20182
20192
202016
202126
202225
202326
202434
202528
202631

By phase

A phase 1/2 study counts in both.

Early Phase 1
11
Phase 1
26
Phase 2
20
Phase 3
32
Phase 4
78
No phase
83

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 48 · Other 195

Janssen Research & Development, LLC (35) · Peking University First Hospital (21) · Beijing Tiantan Hospital (16) · Tianjin Medical University General Hospital (10) · Chinese PLA General Hospital (7) · Second Affiliated Hospital, School of Medicine, Zhejiang University (5) · Second Affiliated Hospital of Wenzhou Medical University (4) · The Second Affiliated Hospital of Chongqing Medical University (4)

Often tested with

Tested in the same studies.

Dexmedetomidine (28) · Propofol (9) · Ketamine (7) · PDCD5 protein, rat (6) · Remimazolam (5) · Remifentanil (3) · Pregabalin (3) · Fentanyl (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 26

Studies that test Esketamine.

Studies

Open first, then newest update. How each study uses Esketamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 243

See all 243 studies that test Esketamine →

Given beside what is tested · 10 — Esketamine is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Esketamine

Codes

What other systems call Esketamine · ClinicalTrials.gg INT001051

  • MeSH (NLM) C000629870EsketamineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 50LFG02TXDESKETAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2119365Confirmed FDA, Wikidata
  • Wikidata Q2365493esketamineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81400EsketamineOne source FDA
  • DrugBank DB11823One source Wikidata

Also registered as esketamine hydrochloride (UNII L8P1H35P2Z · RxNorm 2119366).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.